UVM Dermatologists Quoted in Managed Healthcare Executive Article on Routine Testing of Liver Enzymes

Managed Healthcare Executive: Make lab monitoring of patients taking isotretinoin less routine, more based on symptoms (JUL 8, 2026)

In a viewpoint published recently in JAMA Dermatology, three University of Vermont (UVM) dermatologists—Joseph C. Pierson, M.D., professor of dermatology at the Larner College of Medicine and chair of the UVM Health dermatology department, and two residents, Taylor M. Pong, M.D., and Mark L. Derbyshire, M.D.—called for the end of routine testing of liver enzymes for people taking isotretinoin.